Fine Agrochemicals is enhancing crop quality for fruit and flower growers in agricultural, ornamental and landscape markets using its plant growth regulator (PGR) technology. Its PGR products, made using naturally occurring molecules through fermentation and combined with chemically synthesised compounds, help stimulate plant cells to enhance nutrient levels and targeted growth for improved crop outputs.

EnsiliTech is improving the shelf-life and global accessibility of vaccines and other biological therapeutics by combatting cold chain transport and storage issues. Its novel ensilication technology, designed for both existing and new biopharmaceutical formulations, encases thermally unstable biomolecules within silica nanoshells to prevent environmental degradation. This eliminates the need for cold chain requirements that are expensive, prone to failure and generate significant carbon dioxide emissions.

Uplift360 is developing chemical-based regeneration technologies to recover and reuse critical industrial materials such as carbon fibre and aramid. Its vision is to lead the way in circular economy innovation, creating a future where advanced materials are never wasted. Backed by the UK Defence and Security Accelerator (DASA), Luxembourg Government Directorate of Defence and Innovate UK, it enables circular and secure supply chains for high-performance sectors.

Scarlet Therapeutics is developing a proprietary platform that generates novel red blood cell-based therapeutics (tRBCs) to treat a wide range of diseases. Its technologies are underpinned by learnings from decades of research including the groundbreaking RESTORE clinical study run by NHS Blood and Transplant and the University of Bristol, investigating transfusion of lab-grown blood into patients. By generating tRBCs with high levels of therapeutic proteins from cell lines rather than from donated stem cells, Scarlet Therapeutics aims to address significant efficacy and manufacturing issues faced in the field.

CoED Biosciences is transforming human tissue separation for adoptive cell therapy and research purposes. Its Column of Expansion and Differentiation (CoED) device harnesses the power of chemotaxis and gravity to gently purify and extract immune cells from blood or tumour biopsies. The process preserves both the integrity and functionality of the tissues without the need for magnets or centrifugation, saving valuable time and resources.

Reach Industries is optimising lab and scientist efficiency with its Lumi™ visual intelligence platform. By automating data capture and analysis for experiments, observations and complex scientific workflows, the platform functions as a streamlined operating system that is accelerating R&D, improving compliance and increasing reproducibility.